PROTERIZUMAB

Clinical trials for PROTERIZUMAB explained in plain language.

Never miss a new study

Get alerted when new PROTERIZUMAB trials appear

Sign up with your email to follow new studies for PROTERIZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radiation and immunotherapy join forces against tough pancreatic cancer

Disease control Recruiting now

This early-phase study is testing whether adding low-dose radiation and an immunotherapy drug called pucotenlimab to standard chemotherapy can help control advanced pancreatic cancer. Ten adults with pancreatic cancer who haven't had prior immunotherapy will receive the combinati…

Matched conditions: PROTERIZUMAB

Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC

PROTERIZUMAB

Get alerted when new PROTERIZUMAB trials appear

Radiation and immunotherapy join forces against tough pancreatic cancer